Alexander Stein

Trials

Studies that name Alexander Stein as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-11 23:38 UTC. Open this list on ClinicalTrials.gov

• Ph2
  NCT07176312 · Zanidatamab in Combination With Pembrolizumab and Chemotherapy in HER2 and PD-L1 Positive Metastatic Gastroesophageal Adenocarcinoma (GEA) Patients

  Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest · recruiting · Gastroesophageal Adenocarcinoma, First Line Therapy, HER2 + Gastric Cancer · principal investigator
• Ph2
  NCT06856837 · - IKF/AIO-QUINTIS - Evaluating Fruquintinib in Combination With Tislelizumab in Microsatellite Stable / Proficient Mismatch Repair (MSS/pMMR) Metastatic Colorectal Cancer Without Active Liver Metastases

  Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest · recruiting · Metastatic Colorectal Cancer · principal investigator
• Ph2
  NCT05510895 · Neoadjuvant Encorafenib, Binimetinib and Cetuximab for Patients With BRAF V600E Mutated/pMMR Localized Colorectal Cancer

  AIO-Studien-gGmbH · completed · Colorectal Cancer, Colon Cancer, BRAF V600E · principal investigator
• Ph1/Ph2
  NCT04177602 · Evaluating Trifluridine/Tipiracil Based Chemoradiation in Locally Advanced Rectal Cancer - The Phase I/II TARC Trial

  Universitätsklinikum Hamburg-Eppendorf · terminated · Locally Advanced Rectal Cancer · principal investigator
• Ph2
  NCT03409848 · Ipilimumab or FOLFOX in Combination With Nivolumab and Trastuzumab in HER2 Positive EsophagoGastric Adenocarcinoma

  AIO-Studien-gGmbH · completed · Gastric Cancer, Esophageal Cancer, Adenocarcinoma Gastric · principal investigator
• Ph2
  NCT03174405 · Avelumab and Cetuximab in Combination With FOLFOX in Patients With Previously Untreated Metastatic Colorectal Cancer - The Phase II AVETUX-CRC Trial.

  AIO-Studien-gGmbH · completed · Metastatic Colorectal Cancer · principal investigator

Grants

NIH projects from RePORTER, fetched 2026-11-11 23:38 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 1 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.

No NIH project could be tied to this name by a shared trial or a matching institution.